His lab is working on refining the alanine-scanning assay to some essential residues which will precisely distinguish between fibrils from neurodegenerative tauopathies. He envisions working with this streamlined assay for postmortem neuropathological diagnosis, And maybe for blood screening of tauopathies.The components that figure out whether an